Parkman Healthcare Partners LLC Edwards Lifesciences Corp Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $2.77 Million - $3.74 Million	40,000 New	40,000 $2.77 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $1.87 Million - $2.39 Million	-27,327 Reduced 33.36%	54,579 $4.07 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $6.75 Million - $8.79 Million	81,906 New	81,906 $6.77 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $3.98 Million - $4.59 Million	-50,584 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $5.16 Million - $6.56 Million	-71,947 Reduced 58.72%	50,584 $4.62 Million
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $170,057 - $221,310	2,531 Added 2.11%	122,531 $9.78 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $6.9 Million - $9.23 Million	120,000 New	120,000 $8.29 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.